Andersen MH - Search Results

1

Andersen MH. Andersen MH. Semin Immunopathol. 2017 Apr;39(3):317-326. doi: 10.1007/s00281-016-0593-x. Epub 2016 Sep 27. Semin Immunopathol. 2017. PMID: 27677755 Review.

2

Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.

Andersen MH, Sørensen RB, Brimnes MK, Svane IM, Becker JC, thor Straten P. Andersen MH, et al. J Clin Invest. 2009 Aug;119(8):2245-56. doi: 10.1172/jci38739. J Clin Invest. 2009. PMID: 19662679 Free PMC article.

3

The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase.

Sørensen RB, Berge-Hansen L, Junker N, Hansen CA, Hadrup SR, Schumacher TN, Svane IM, Becker JC, thor Straten P, Andersen MH. Sørensen RB, et al. Among authors: andersen mh. PLoS One. 2009 Sep 7;4(9):e6910. doi: 10.1371/journal.pone.0006910. PLoS One. 2009. PMID: 19738905 Free PMC article.

4

Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.

Sørensen RB, Hadrup SR, Svane IM, Hjortsø MC, Thor Straten P, Andersen MH. Sørensen RB, et al. Among authors: andersen mh. Blood. 2011 Feb 17;117(7):2200-10. doi: 10.1182/blood-2010-06-288498. Epub 2010 Nov 15. Blood. 2011. PMID: 21079151 Free PMC article.

5

Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2.

Bjoern J, Brimnes MK, Andersen MH, Thor Straten P, Svane IM. Bjoern J, et al. Among authors: andersen mh. Scand J Immunol. 2011 Mar;73(3):222-33. doi: 10.1111/j.1365-3083.2010.02494.x. Scand J Immunol. 2011. PMID: 21204893 Free article. Clinical Trial.

6

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

Sørensen RB, Køllgaard T, Andersen RS, van den Berg JH, Svane IM, Straten Pt, Andersen MH. Sørensen RB, et al. Among authors: andersen rs, andersen mh. Cancer Res. 2011 Mar 15;71(6):2038-44. doi: 10.1158/0008-5472.CAN-10-3403. Cancer Res. 2011. PMID: 21406395

7

The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase.

Andersen MH. Andersen MH. Cancer Immunol Immunother. 2012 Aug;61(8):1289-97. doi: 10.1007/s00262-012-1234-4. Epub 2012 Mar 3. Cancer Immunol Immunother. 2012. PMID: 22388712 Free PMC article. Review.

8

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase.

Munir S, Larsen SK, Iversen TZ, Donia M, Klausen TW, Svane IM, Straten PT, Andersen MH. Munir S, et al. Among authors: andersen mh. PLoS One. 2012;7(4):e34568. doi: 10.1371/journal.pone.0034568. Epub 2012 Apr 23. PLoS One. 2012. PMID: 22539948 Free PMC article.

9

The targeting of immunosuppressive mechanisms in hematological malignancies.

Andersen MH. Andersen MH. Leukemia. 2014 Sep;28(9):1784-92. doi: 10.1038/leu.2014.108. Epub 2014 Mar 18. Leukemia. 2014. PMID: 24691076 Review.

10

Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology.

Andersen MH. Andersen MH. Immunol Res. 2014 Dec;60(2-3):156-64. doi: 10.1007/s12026-014-8559-3. Immunol Res. 2014. PMID: 25381479 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page